EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lanxess AG's EBITDA for the
three
months ended in Mar. 2026 was €-4 Mil. Lanxess AG's Revenue for the
three
months ended in Mar. 2026 was €1,378 Mil. Therefore, Lanxess AG's EBITDA margin for the quarter that ended in Mar. 2026 was -0.29%.
Lanxess AG (STU:LXS) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Lanxess AG EBITDA Margin % Related Terms
Lanxess AG EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Lanxess AG's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:LXS vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Lanxess AG's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lanxess AG EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Lanxess AG's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Lanxess AG's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lanxess AG (STU:LXS) has a EBITDA Margin % of -0.29% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lanxess AG and its competitors. Over the past decade, Lanxess AG's EBITDA Margin % has ranged from 2.16 to 27.28. According to the industry distribution chart, Lanxess AG ranks #1028 out of 1580 companies in the Chemicals industry, placing it in the top 65.1%.
Is Lanxess AG's EBITDA Margin % too high?
Lanxess AG's current EBITDA Margin % is -0.29%. Over the past 10 years, this metric has ranged from a low of 2.16 to a high of 27.28. Based on the distribution chart, Lanxess AG ranks #1028 out of 1580 companies in the Chemicals industry, which is below the industry midpoint. Overall, Lanxess AG has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lanxess AG's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Lanxess AG ranks #1028 out of 1580 companies for EBITDA Margin %. This places Lanxess AG in the lower half of its industry. The industry median EBITDA Margin % is 9.63. Historically, Lanxess AG's own EBITDA Margin % has ranged from 2.16 to 27.28 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Lanxess AG and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lanxess AG's current EBITDA Margin % is -0.29%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lanxess AG stock overvalued right now?
Based on GuruFocus' analysis, Lanxess AG (STU:LXS) is currently considered Modestly Undervalued. The stock's GF Value™ is €20.38, compared to a current price of €16.08 — trading 21.1% below its estimated fair value. The current EBITDA Margin % is -0.29%. Lanxess AG's overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Lanxess AG (STU:LXS), the current EBITDA Margin % is -0.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lanxess AG (STU:LXS) Overvalued in 2026?
Based on GuruFocus' analysis, Lanxess AG stock appears to be undervalued.
The current stock price of €16.08 is trading 21.1% below its estimated GF Value™ of €20.38.
GuruFocus considers Lanxess AG to be Modestly Undervalued.
Key valuation signals for STU:LXS:
EBITDA Margin %: -0.29%
GF Value™: €20.38 vs. price of €16.08 (21.1% below fair value)
No single metric tells the full story. See the STU:LXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lanxess AG is a German chemical company that was originally spun out of Bayer. Lanxess has visibly decommoditised its portfolio by divesting its synthetic rubber business. It has business segments, namely: specialty chemicals company in the fields of consumer protection chemicals, specialty additives, advanced intermediates, and all other segments. Geographically, it operates in EMEA (excluding Germany), Germany, the Americas, and Asia-Pacific.
65GF Score
Get the complete analysis for STU:LXS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LXS has been successfully added to your 
